Beauty Boom: What’s driving the aesthetics growth in emerging markets?
Helen Ansell explores why aesthetics is one of the most lucrative areas for the pharmaceutical and healthcare industries in emerging markets.
Aesthetics have always been a lucrative area for the pharmaceutical and healthcare industries, particularly in developed markets. There are several factors contributing to growth in the aesthetics market. Women today have more spending power than ever before. In the US alone the aesthetics market is expected to reach USD $4.4 billion by 2021. However, what has really grabbed my attention as a researcher specialising in emerging markets and cosmetics, is the huge growth in demand in developing markets over the past few years, strongly reinforcing the opportunities for healthcare companies across the globe.
Towards a culture of evaluation and evidence-based decision making in global health
Reflections on THET Conference 2016: Evidence, Effectiveness & Impact
Last week we attended THET’s annual conference in London. As researchers specializing in qualitative and quantitative methodologies, the theme of evidence, effectiveness and impact was a particularly relevant one for us. Monitoring and evaluation are increasingly being recognized as critical components in establishing the impact of any global health intervention. It was interesting to gain an understanding of the latest thinking in this area from a health partnership perspective.